Vaxvec Home

Introduction

Statistics

News and Updates

Vaxvec Vectors

Vaxvec Vaccines

Vaxvec Antigens

VaxvecAg BLAST

Selected Vectors

B. abortus RB51 vector

RSV vaccine vector

SL3261 vaccine vector

VSV vaccine vector

Data Submission

Data Exchange

Data Download

Documentation

FAQs

Disclaimer

Contact Us

VaxvecAg: Protective Antigens used in Verified Recombinant Vector Vaccines

     Protective antigens are specifically targeted by the acquired immune response of the host and are able to induce protection in the host against infectious and non-infectious diseases. This page includes those protective antigens that have been used in verified recombinant vector vaccines.

DNAVaxAg Search
Search Field	Search Parameter
Pathogen or Disease	Any pathogen Ebola virus Actinobacillus pleuropneumoniae Marburg Virus Mycobacterium tuberculosis Escherichia coli Streptococcus pneumoniae Rabies virus Pseudorabies virus SARS-CoV Canine distemper virus Rotavirus Feline leukemia virus Newcastle disease virus Neospora caninum Helicobacter pylori Nipah virus Mumps virus Measles virus Porcine circovirus 2 Human Papillomavirus Influenza virus Leishmania donovani Japanese encephalitis virus Cancer Classical swine fever virus Human Immunodeficiency Virus Bacillus anthracis Herpes simplex virus type 1 and 2 West Nile virus Infectious Bursal Disease Virus (IBDV) Rabbit hemorrhagic disease virus Infectious Bronchitis Virus (IBV) Leishmania major Plasmodium spp. Mycoplasma hyopneumoniae Toxoplasma gondii
Gene Name	(e.g., sodC)
Locus Tag	(e.g., BAB2_0535)
Database ID	NCBI Gene GI NCBI Nucleotide GI NCBI Protein Accesion No NCBI Protein GI Protegen ID VO ID Other Database ID
Description	(e.g., superoxide dismutase)

 

Statistics: 78 protective antigens used in recombinant vector vaccines have been identified for now.